Brewer J M, Alexander J
Immunology Department, University of Strathclyde, Glasgow, U.K.
Immunology. 1992 Apr;75(4):570-5.
The ability of non-ionic surfactant vesicles (NISV) to enhance antibody production against bovine serum albumin (BSA) was compared with Freund's complete adjuvant (FCA), in the BALB/c mouse. Two subcutaneous inoculations with NISV entrapped BSA induced antibody levels comparable to, and persisting as long as those produced by FCA by either the subcutaneous or intraperitoneal route of inoculation. Intraperitoneal inoculation of NISV did not generate as strong an antibody response. The adjuvant activity of NISV was wholly dependent on the BSA being entrapped within preformed vesicles; mixing free BSA with vesicles was not effective. Analysis of the anti-BSA IgG subclasses induced by NISV and FCA showed that NISV were generally better stimulators of IgG2a than was FCA, but poorer stimulators of IgG1. From this, we deduce that NISV are potentially better stimulators of the Th1 lymphocyte subset than is FCA and by inference, potent stimulators of cellular immunity. We believe that NISV may offer many advantages over other adjuvants in terms of immunological selectivity, low toxicity and stability.
在BALB/c小鼠中,比较了非离子表面活性剂囊泡(NISV)与弗氏完全佐剂(FCA)增强抗牛血清白蛋白(BSA)抗体产生的能力。用包封有BSA的NISV进行两次皮下接种所诱导的抗体水平,与通过皮下或腹腔接种途径用FCA产生的抗体水平相当,且持续时间相同。腹腔接种NISV并未产生同样强烈的抗体反应。NISV的佐剂活性完全取决于BSA被包封在预先形成的囊泡内;将游离BSA与囊泡混合无效。对由NISV和FCA诱导的抗BSA IgG亚类的分析表明,NISV通常比FCA更能有效刺激IgG2a的产生,但刺激IgG1的能力较弱。由此,我们推断NISV可能比FCA更能有效刺激Th1淋巴细胞亚群,进而推断其是细胞免疫的有效刺激剂。我们认为,在免疫选择性、低毒性和稳定性方面,NISV可能比其他佐剂具有许多优势。